Researchers evidence suggests it’s the lessening of amyloid-beta in the brain that is behind cognitive decline.

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive ...

Researchers confirm plasma pTau181 is a strong predictor for Alzheimer's in patients with mild cognitive impairment, offering ...

A new study helps explain why having ApoE4—the gene variant most closely linked to Alzheimer's disease—increases the risk of ...

The ALPS index effectively distinguishes individuals with SCD from those with normal cognition and is correlated with amyloid beta burden.

GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based ...

The plaque building is one component of Alzheimer's disease pathology, the release said. A hallmark of Alzheimer's is the ...

GE HealthCare’s MIM Software receives US FDA clearance of new Centiloid scaling tool to quantify amyloid plaque in brain imaging: Chicago Thursday, September 19, 2024, 12:00 Hrs ...